Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time.

MLA

Khanna, Avinash, et al. “Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time.” ACS Medicinal Chemistry Letters, vol. 11, no. 6, Mar. 2020, pp. 1205–12. EBSCOhost, https://doi.org/10.1021/acsmedchemlett.0c00045.

APA

Khanna, A., Côté, A., Arora, S., Moine, L., Gehling, V. S., Brenneman, J., Cantone, N., Stuckey, J. I., Apte, S., Ramakrishnan, A., Bruderek, K., Bradley, W. D., Audia, J. E., Cummings, R. T., Sims, R. J., 3rd, Trojer, P., & Levell, J. R. (2020). Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time. ACS Medicinal Chemistry Letters, 11(6), 1205–1212. https://doi.org/10.1021/acsmedchemlett.0c00045

Chicago

Khanna, Avinash, Alexandre Côté, Shilpi Arora, Ludivine Moine, Victor S Gehling, Jehrod Brenneman, Nico Cantone, et al. 2020. “Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time.” ACS Medicinal Chemistry Letters 11 (6): 1205–12. doi:10.1021/acsmedchemlett.0c00045.